Coherus Oncology (CHRS) Shares Outstanding (2013 - 2026)

Coherus Oncology (CHRS) Shares Outstanding (2013 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	6,012.74 Bn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	47.82 Bn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	1.44 Bn
4	NuCana	279.75 Bn	279.75 Bn	-	11.23 Bn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	254.10 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	400.00 Mn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	62.19 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	198.10 Mn
10	Coherus Oncology	195.05 Mn	28.00 Mn	8.50 Mn	136.40 Mn

Download Data